Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rufinamide for Chronic Postthoracotomy Pain Syndrome
NCT02095899Phase 2Withdrawn
- Sponsor
- University of Zurich
- Start
- Mar 2014
- Primary completion
- May 2015
- Modality
- Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of rufinamide in post-thoracotomy pain syndrome (PTPS), sponsored by University of Zurich. Planned start Mar 2014; status: withdrawn.
02
Drugs
rufinamide
03
Conditions
post-thoracotomy pain syndrome (PTPS)
Beyond the preview
Go deeper on NCT02095899.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02095899.